Latest news with #HASHIMOTOOsamu
Fibre2Fashion
28-05-2025
- Business
- Fibre2Fashion
Japan's Mitsui Chemicals plans NF3 exit by March 2026
Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu) has decided to withdraw from the nitrogen trifluoride (NF3) business. Currently manufactured by the company's wholly owned subsidiary, Shimonoseki Mitsui Chemicals, Inc. (Shimonoseki, Yamaguchi; President & CEO: YOKAWA Naokazu). Production will cease at the end of March 2026, and sales will end within the same year. Mitsui Chemicals will exit the nitrogen trifluoride (NF3) business by end-2026, ceasing production at its Shimonoseki subsidiary in March. The move aligns with its VISION 2030 plan to shift toward global specialty and green chemicals. Intense price competition, rising input costs, and limited profitability drove the decision despite cost-cutting efforts. Background to the business withdrawal Mitsui Chemicals' VISION 2030 Long-Term Business Plan positions 'Chemistry for Sustainable World' as the company's ideal vision. In pursuing portfolio reform as a basic strategy for achieving this plan, Mitsui Chemicals aims to become a truly global specialty company by leaning on the two key pillars of a high-growth, high-profitability global specialty chemicals business, and a sustainable green chemicals business centered on competitive derivatives. The Semiconductor & Optical Materials Division of Mitsui Chemicals' ICT Solutions Business Sector is engaged in business associated with NF3, a gas used as a cleaning agent for semiconductor and liquid crystal display manufacturing equipment. However, the profitability of the business has been placed under extreme pressure by escalating price competition with overseas products, increasing raw material and utility costs, and rising repair and other costs. In response to this situation, Mitsui Chemicals has undertaken all possible efforts to rationalize the business and reduce costs, but has now determined that it is unfeasible to ensure the level of profitability required to sustain the business and has therefore decided to withdraw from it. Note: The headline, insights, and image of this press release may have been refined by the Fibre2Fashion staff; the rest of the content remains unchanged. Fibre2Fashion News Desk (HU)
Yahoo
26-05-2025
- Business
- Yahoo
Mitsui Chemicals Launches New Corporate Venture Capital Fund ‘321Catalyst™'
TOKYO, May 26, 2025--(BUSINESS WIRE)--Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu), a global chemicals manufacturer based in Japan, today announced the launch of its second Corporate Venture Capital Fund '321Catalyst™,' as well as the establishment of a new subsidiary '321Catalyst Ventures, Inc.,' which will manage the on the success of its first fund, '321FORCE™,' launched with Japanese venture capital Global Brain in 2022, 321Catalyst™'s mission will be to accelerate the building of global innovation partnerships and the launching of new products and business. Through the establishment of the new, independent fund in the USA, Mitsui Chemicals is doubling down on global investments in innovative startups that align with its strategic focus. Strong innovation partnerships with its portfolio companies will allow Mitsui Chemicals to launch new businesses ahead of the race. 321Catalyst™ will have a fund size of $60 million and a life of 10 years. Mitsui Chemicals intends to enhance and strengthen its Basic Strategy of 'building solutions-based business models' as manifested in its Long-Term Business Plan, VISION 2030. Consistent with this goal, Mitsui Chemicals will continue investing in startups across the world to escalate the launching of new products and new businesses as well as the transformation of its business portfolio. Overview of 321Catalyst™, the new Corporate Venture Capital Fund Registered Name 321Catalyst LP Address San Jose, CA, USA Fund Size $60 million Date of Establishment May 6th, 2025 Fund Life 10 years Focus Stage Seed and at all stages beyond Focus Region Global (USA, Europe, Asia, etc.) Focus Industry All industries including Life & Healthcare, Mobility, ICT, Sustainability, and other new industries General Partner 321Catalyst Ventures, Inc. Limited Partner 321Indigo Ventures, Inc. (100% subsidiary of Mitsui Chemicals) Overview of the new subsidiary acting as the General Partner Registered Name 321Catalyst Ventures, Inc. Address San Jose, CA, USA Representative Shunsuke Fujii (President) Business Overview Management of Corporate Venture Capital Funds Date of Establishment April 10th, 2025 Ownership 100% owned by Mitsui Chemicals America, Inc View source version on Contacts For inquiries about this release, please contact:Corporate Communications Division, Mitsui Chemicals, +81-3-6880-7500Inquiry form:
Business Wire
26-05-2025
- Business
- Business Wire
Mitsui Chemicals Launches New Corporate Venture Capital Fund ‘321Catalyst™'
TOKYO--(BUSINESS WIRE)--Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu), a global chemicals manufacturer based in Japan, today announced the launch of its second Corporate Venture Capital Fund '321Catalyst™,' as well as the establishment of a new subsidiary '321Catalyst Ventures, Inc.,' which will manage the fund. Building on the success of its first fund, '321FORCE™,' launched with Japanese venture capital Global Brain in 2022, 321Catalyst™'s mission will be to accelerate the building of global innovation partnerships and the launching of new products and business. Through the establishment of the new, independent fund in the USA, Mitsui Chemicals is doubling down on global investments in innovative startups that align with its strategic focus. Strong innovation partnerships with its portfolio companies will allow Mitsui Chemicals to launch new businesses ahead of the race. 321Catalyst™ will have a fund size of $60 million and a life of 10 years. Mitsui Chemicals intends to enhance and strengthen its Basic Strategy of 'building solutions-based business models' as manifested in its Long-Term Business Plan, VISION 2030. Consistent with this goal, Mitsui Chemicals will continue investing in startups across the world to escalate the launching of new products and new businesses as well as the transformation of its business portfolio. Overview of 321Catalyst™, the new Corporate Venture Capital Fund Registered Name 321Catalyst LP Address San Jose, CA, USA Fund Size $60 million Date of Establishment May 6 th, 2025 Fund Life 10 years Focus Stage Seed and at all stages beyond Focus Region Global (USA, Europe, Asia, etc.) Focus Industry All industries including Life & Healthcare, Mobility, ICT, Sustainability, and other new industries General Partner 321Catalyst Ventures, Inc. Limited Partner 321Indigo Ventures, Inc. (100% subsidiary of Mitsui Chemicals) Expand Overview of the new subsidiary acting as the General Partner Registered Name 321Catalyst Ventures, Inc. Address San Jose, CA, USA Representative Shunsuke Fujii (President) Business Overview Management of Corporate Venture Capital Funds Date of Establishment April 10 th, 2025 Ownership 100% owned by Mitsui Chemicals America, Inc Expand
National Post
26-05-2025
- Business
- National Post
Mitsui Chemicals Launches New Corporate Venture Capital Fund '321Catalyst™'
Article content Article content Article content TOKYO — Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu), a global chemicals manufacturer based in Japan, today announced the launch of its second Corporate Venture Capital Fund '321Catalyst™,' as well as the establishment of a new subsidiary '321Catalyst Ventures, Inc.,' which will manage the fund. Building on the success of its first fund, '321FORCE™,' launched with Japanese venture capital Global Brain in 2022, 321Catalyst™'s mission will be to accelerate the building of global innovation partnerships and the launching of new products and business. Through the establishment of the new, independent fund in the USA, Mitsui Chemicals is doubling down on global investments in innovative startups that align with its strategic focus. Strong innovation partnerships with its portfolio companies will allow Mitsui Chemicals to launch new businesses ahead of the race. 321Catalyst™ will have a fund size of $60 million and a life of 10 years. Article content Mitsui Chemicals intends to enhance and strengthen its Basic Strategy of 'building solutions-based business models' as manifested in its Long-Term Business Plan, VISION 2030. Consistent with this goal, Mitsui Chemicals will continue investing in startups across the world to escalate the launching of new products and new businesses as well as the transformation of its business portfolio. Article content Article content Article content Article content Article content Article content
